Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia

被引:39
作者
Gunawan, Arief S. [1 ]
McLornan, Donal P. [1 ]
Wilkins, Bridget [1 ]
Waghorn, Katherine [2 ,3 ]
Hoade, Yvette [2 ,3 ]
Cross, Nicholas C. P. [2 ,3 ]
Harrison, Claire N. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Univ Southampton, Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Southampton, Hants, England
[3] Univ Southampton, Fac Med, Southampton, Hants, England
关键词
ATYPICAL CML; THERAPY;
D O I
10.3324/haematol.2017.163790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E238 / E240
页数:3
相关论文
共 9 条
[1]   Chronic neutrophilic leukaemia:: 14 new cases of an uncommon myeloproliferative disease [J].
Böhm, J ;
Schaefer, HE .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (11) :862-864
[2]   Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis [J].
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Kiladjian, Jean-Jacques ;
Al-Ali, Haifa Kathrin ;
Sirulnik, Andres ;
Stalbovskaya, Viktoriya ;
McQuitty, Mari ;
Hunter, Deborah S. ;
Levy, Richard S. ;
Passamonti, Francesco ;
Barbui, Tiziano ;
Barosi, Giovanni ;
Harrison, Claire N. ;
Knoops, Laurent ;
Gisslinger, Heinz .
BLOOD, 2013, 122 (25) :4047-4053
[3]  
Dao Kim-Hien T, 2014, Leuk Res Rep, V3, P67, DOI 10.1016/j.lrr.2014.07.002
[4]   WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature [J].
Elliott, MA ;
Hanson, CA ;
Dewald, GW ;
Smoley, SA ;
Lasho, TL ;
Tefferi, A .
LEUKEMIA, 2005, 19 (02) :313-317
[5]   The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment [J].
Gotlib, Jason ;
Maxson, Julia E. ;
George, Tracy I. ;
Tyner, Jeffrey W. .
BLOOD, 2013, 122 (10) :1707-1711
[6]   Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy [J].
Koppikar, Priya ;
Bhagwat, Neha ;
Kilpivaara, Outi ;
Manshouri, Taghi ;
Adli, Mazhar ;
Hricik, Todd ;
Liu, Fan ;
Saunders, Lindsay M. ;
Mullally, Ann ;
Abdel-Wahab, Omar ;
Leung, Laura ;
Weinstein, Abby ;
Marubayashi, Sachie ;
Goel, Aviva ;
Goenen, Mithat ;
Estrov, Zeev ;
Ebert, Benjamin L. ;
Chiosis, Gabriela ;
Nimer, Stephen D. ;
Bernstein, Bradley E. ;
Verstovsek, Srdan ;
Levine, Ross L. .
NATURE, 2012, 489 (7414) :155-U222
[7]   Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib [J].
Lasho, T. L. ;
Mims, A. ;
Elliott, M. A. ;
Finke, C. ;
Pardanani, A. ;
Tefferi, A. .
LEUKEMIA, 2014, 28 (06) :1363-1365
[8]   Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML [J].
Maxson, Julia E. ;
Gotlib, Jason ;
Pollyea, Daniel A. ;
Fleischman, Angela G. ;
Agarwal, Anupriya ;
Eide, Christopher A. ;
Bottomly, Daniel ;
Wilmot, Beth ;
McWeeney, Shannon K. ;
Tognon, Cristina E. ;
Pond, J. Blake ;
Collins, Robert H. ;
Goueli, Basem ;
Oh, Stephen T. ;
Deininger, Michael W. ;
Chang, Bill H. ;
Loriaux, Marc M. ;
Druker, Brian J. ;
Tyner, Jeffrey W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (19) :1781-1790
[9]   Recurrent SETBP1 mutations in atypical chronic myeloid leukemia [J].
Piazza, Rocco ;
Valletta, Simona ;
Winkelmann, Nils ;
Redaelli, Sara ;
Spinelli, Roberta ;
Pirola, Alessandra ;
Antolini, Laura ;
Mologni, Luca ;
Donadoni, Carla ;
Papaemmanuil, Elli ;
Schnittger, Susanne ;
Kim, Dong-Wook ;
Boultwood, Jacqueline ;
Rossi, Fabio ;
Gaipa, Giuseppe ;
De Martini, Greta P. ;
Di Celle, Paola Francia ;
Jang, Hyun Gyung ;
Fantin, Valeria ;
Bignell, Graham R. ;
Magistroni, Vera ;
Haferlach, Torsten ;
Pogliani, Enrico Maria ;
Campbell, Peter J. ;
Chase, Andrew J. ;
Tapper, William J. ;
Cross, Nicholas C. P. ;
Gambacorti-Passerini, Carlo .
NATURE GENETICS, 2013, 45 (01) :18-U41